LIXT
NASDAQ · Biotechnology
Lixte Biotechnology Holdings
$2.95
-0.07 (-2.32%)
Open$3.05
Previous Close$3.02
Day High$3.08
Day Low$2.84
52W High$23.93
52W Low$20.54
Volume—
Avg Volume682.7K
Market Cap23.64M
P/E Ratio56.57
EPS$0.40
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 2.59M | 2.67M | 2.41M |
| Net Income | 404.7K | 492.8K | 436.5K |
| Profit Margin | 15.6% | 18.4% | 18.1% |
| EBITDA | 711.7K | 711.0K | 701.7K |
| Free Cash Flow | 315.8K | 252.8K | 287.8K |
| Rev Growth | +13.7% | +15.1% | +4.1% |
| Debt/Equity | 1.15 | 1.36 | 1.30 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |